Adam Lezack - 01 Dec 2025 Form 4 Insider Report for Beta Bionics, Inc. (BBNX)

Role
Director
Signature
/s/ Stephen Feider, Attorney-in-Fact
Issuer symbol
BBNX
Transactions as of
01 Dec 2025
Net transactions value
-$41,543
Form type
4
Filing time
02 Dec 2025, 16:20:08 UTC
Previous filing
05 Nov 2025
Next filing
14 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lezack Adam Director C/O BETA BIONICS, INC., 11 HUGHES, IRVINE /s/ Stephen Feider, Attorney-in-Fact 02 Dec 2025 0002048466

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBNX Common Stock Sale $26,588 -906 -9.2% $29.35 8,935 01 Dec 2025 Direct F1, F2
transaction BBNX Common Stock Sale $14,955 -500 -5.6% $29.91 8,435 01 Dec 2025 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025.
F2 The weighted average sale price for the transaction reported was $29.3463 and the range of prices were between $28.75 and $29.63. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
F3 The weighted average sale price for the transaction reported was $29.91 and the range of prices were between $29.80 and $30.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.